Ascentage Pharma Group International (HKG: 6855)
Hong Kong
· Delayed Price · Currency is HKD 41.05
-3.15 (-7.13%)
Nov 13, 2024, 4:08 PM HKT
Ascentage Pharma Group International Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -360.29 | -925.64 | -882.92 | -782.42 | -677.61 | -1,481 | Upgrade
|
| Depreciation & Amortization | 92.54 | 90.81 | 60.92 | 27.53 | 26.49 | 25.79 | Upgrade
|
| Other Amortization | 2.39 | 2.39 | 2 | 0.8 | 0.93 | 0.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | -0 | -2.27 | 0.03 | 0 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.7 | 0.7 | 9.77 | 20.89 | 3.75 | 30.69 | Upgrade
|
| Loss (Gain) on Equity Investments | -1.08 | -1.08 | 0.28 | - | - | - | Upgrade
|
| Stock-Based Compensation | 31.5 | 31.5 | 22.11 | 46.97 | 74.03 | 70.82 | Upgrade
|
| Other Operating Activities | -468.63 | 84.39 | 31.81 | -108.13 | 10.19 | 881.28 | Upgrade
|
| Change in Accounts Receivable | -91.54 | -91.54 | -0.39 | -53.97 | - | - | Upgrade
|
| Change in Inventory | -6.72 | -6.72 | -5.52 | -3.93 | - | - | Upgrade
|
| Change in Accounts Payable | -23.11 | -23.11 | 24.7 | 47.5 | 10.28 | 8 | Upgrade
|
| Change in Unearned Revenue | 82.98 | 82.98 | -24.66 | 227.39 | 5.11 | 8.07 | Upgrade
|
| Change in Other Net Operating Assets | 29.24 | 29.24 | 110.28 | -17.01 | -55.25 | 3.46 | Upgrade
|
| Operating Cash Flow | -712 | -726.08 | -653.92 | -604.68 | -609.96 | -460.31 | Upgrade
|
| Capital Expenditures | -28.66 | -46.11 | -203.29 | -435.42 | -249.92 | -77.46 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | 2.35 | 0.34 | - | - | Upgrade
|
| Cash Acquisitions | -20 | -20 | -20 | -20 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -9.93 | -10.74 | -33.68 | -1.21 | -1.56 | -3.96 | Upgrade
|
| Investment in Securities | 14 | 98.75 | -130 | -10.23 | 144.11 | -119.92 | Upgrade
|
| Investing Cash Flow | -44.58 | 21.92 | -384.61 | -466.52 | -107.37 | -201.33 | Upgrade
|
| Long-Term Debt Issued | - | 953.5 | 763.62 | 599.74 | 527.81 | 85 | Upgrade
|
| Long-Term Debt Repaid | - | -966.86 | -67.74 | -60.24 | -102.67 | -42.66 | Upgrade
|
| Net Debt Issued (Repaid) | -141.84 | -13.36 | 695.87 | 539.5 | 425.14 | 42.34 | Upgrade
|
| Issuance of Common Stock | 533.95 | 470.09 | 0.02 | 1,197 | 634.22 | 432.28 | Upgrade
|
| Repurchase of Common Stock | -7.88 | -5.92 | -26.78 | -25.87 | - | - | Upgrade
|
| Other Financing Activities | -74.2 | -82.06 | -49.85 | 70.97 | -19.35 | -32.26 | Upgrade
|
| Financing Cash Flow | 310.02 | 368.75 | 619.27 | 1,781 | 1,040 | 442.36 | Upgrade
|
| Foreign Exchange Rate Adjustments | 9.01 | 27.81 | 58.01 | -23.28 | -41.69 | 1.17 | Upgrade
|
| Net Cash Flow | -437.56 | -307.59 | -361.25 | 686.91 | 280.99 | -218.1 | Upgrade
|
| Free Cash Flow | -740.66 | -772.19 | -857.2 | -1,040 | -859.88 | -537.76 | Upgrade
|
| Free Cash Flow Margin | -82.02% | -347.86% | -408.75% | -3726.60% | -6906.64% | -3705.37% | Upgrade
|
| Free Cash Flow Per Share | -2.55 | -2.74 | -3.25 | -4.08 | -3.98 | -4.61 | Upgrade
|
| Cash Interest Paid | 71.13 | 92.35 | 49.85 | 16.81 | 5.94 | 4.27 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 3.85 | - | - | Upgrade
|
| Levered Free Cash Flow | -771.16 | -706.12 | -680.98 | -954.65 | -493.55 | -334.76 | Upgrade
|
| Unlevered Free Cash Flow | -722.77 | -646.09 | -647.99 | -944.19 | -489.65 | -332.09 | Upgrade
|
| Change in Net Working Capital | 586.05 | 156.45 | -56.08 | -0.38 | -88.15 | -35.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.